{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:02:31Z","timestamp":1770642151385,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Survival rates from colorectal cancer (CRC) are drastically higher if the disease is detected and treated earlier. Current screening guidelines involve stool-based tests and colonoscopies, whose acceptability and uptake remains low. Routinely collected blood-based biomarkers may offer a low-cost alternative or aid for detecting CRC. Here we aimed to evaluate the pre-diagnostic and diagnostic value of a wide-range of multimodal biomarkers in the UK Biobank dataset, including sociodemographic, lifestyle, medical, physical, and blood and urine-based measures in detecting CRC. We performed a Cox proportional hazard and a tree-boosting model alongside feature selection methods to determine optimal combination of biomarkers. In addition to the modifiable lifestyle factors of obesity, alcohol consumption and cardiovascular health, we showed that blood-based biomarkers that capture the immune response, lipid profile, liver and kidney function are associated with CRC risk. Following feature selection, the final Cox and tree-boosting models achieved a C-index of 0.67 and an AUC of 0.76 respectively. We show that blood-based biomarkers collected in routine examinations are sensitive to preclinical and clinical CRC. They may provide an additive value and improve diagnostic accuracy of current screening tools at no additional cost and help reduce burden on the healthcare system.<\/jats:p>","DOI":"10.1038\/s41598-023-28631-y","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T19:02:32Z","timestamp":1674586952000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Additive pre-diagnostic and diagnostic value of routine blood-based biomarkers in the detection of colorectal cancer in the UK Biobank cohort"],"prefix":"10.1038","volume":"13","author":[{"given":"Gizem","family":"Tanriver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ece","family":"Kocagoncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"28631_CR1","unstructured":"Caul, S., & Broggio, J. Cancer registration statistics, England: 2017 [Internet]. 2019 Apr [cited 2022 Oct 6]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/cancerregistrationstatisticsengland\/2017#:~:text=In%202017%2C%20the%20number%20of,%25)%20and%20females%20(63.3%25)."},{"key":"28631_CR2","unstructured":"John, S., & Broggio, J. Cancer survival in England: national estimates for patients followed up to 2017 [Internet]. 2019 Jan [cited 2022 Oct 6]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/bulletins\/cancersurvivalinengland\/nationalestimatesforpatientsfollowedupto2017."},{"key":"28631_CR3","unstructured":"Cancer Research UK. Bowel cancer incidence statistics [Internet]. 2021 [cited 2022 Oct 17]. Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer\/incidence."},{"issue":"41","key":"28631_CR4","doi-asserted-by":"publisher","first-page":"11767","DOI":"10.3748\/wjg.v21.i41.11767","volume":"21","author":"S Vatandoust","year":"2015","unstructured":"Vatandoust, S., Price, T. J. & Karapetis, C. S. Colorectal cancer: Metastases to a single organ. World J. Gastroenterol. 21(41), 11767\u201311776 (2015).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"28631_CR5","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers, E. J. et al. Colorectal cancer. Nat. Rev. Dis. Primers. 1(1), 15065 (2015).","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"3","key":"28631_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10198-019-01130-6","volume":"21","author":"P Joranger","year":"2020","unstructured":"Joranger, P. et al. Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: A model approach. Eur. J. Heal. Econ. 21(3), 321\u2013334 (2020).","journal-title":"Eur. J. Heal. Econ."},{"issue":"3","key":"28631_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.7326\/M13-1484","volume":"160","author":"JK Lee","year":"2014","unstructured":"Lee, J. K., Liles, E. G., Bent, S., Levin, T. R. & Corley, D. A. Accuracy of fecal immunochemical tests for colorectal cancer: Systematic review and meta-analysis. Ann. Intern. Med. 160(3), 171\u2013181 (2014).","journal-title":"Ann. Intern. Med."},{"issue":"14","key":"28631_CR8","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","volume":"370","author":"TF Imperiale","year":"2014","unstructured":"Imperiale, T. F. et al. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med. 370(14), 1287\u20131297 (2014).","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"28631_CR9","first-page":"102","volume":"6","author":"TG Delisle","year":"2022","unstructured":"Delisle, T. G. et al. Faecal immunochemical test for suspected colorectal cancer symptoms: Patient survey of usability and acceptability. BJGP Open. 6(1), 102 (2022).","journal-title":"BJGP Open."},{"key":"28631_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctarc.2016.12.004","volume":"10","author":"EG Liles","year":"2017","unstructured":"Liles, E. G. et al. Uptake of a colorectal cancer screening blood test is higher than of a fecal test offered in clinic: A randomized trial. Cancer Treat Res. Commun. 10, 27\u201331 (2017).","journal-title":"Cancer Treat Res. Commun."},{"key":"28631_CR11","doi-asserted-by":"publisher","first-page":"2195361","DOI":"10.1155\/2017\/2195361","volume":"2017","author":"N Hauptman","year":"2017","unstructured":"Hauptman, N. & Glava\u010d, D. Colorectal cancer blood-based biomarkers. Gastroent. Res. Pract. 2017, 2195361 (2017).","journal-title":"Gastroent. Res. Pract."},{"issue":"31","key":"28631_CR12","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.3748\/wjg.v25.i31.4383","volume":"25","author":"AE Tuomisto","year":"2019","unstructured":"Tuomisto, A. E., M\u00e4kinen, M. J. & V\u00e4yrynen, J. P. Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance. World J. Gastroenterol. 25(31), 4383\u20134404 (2019).","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"28631_CR13","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.3390\/cancers12092348","volume":"12","author":"PS Virdee","year":"2020","unstructured":"Virdee, P. S. et al. The full blood count blood test for colorectal cancer detection: A systematic review, meta-analysis, and critical appraisal. Cancers 12(9), 2348 (2020).","journal-title":"Cancers"},{"issue":"5","key":"28631_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3349\/ymj.2006.47.5.646","volume":"47","author":"YJ Lee","year":"2006","unstructured":"Lee, Y. J., Lee, H. R., Nam, C. M., Hwang, U. K. & Jee, S. H. White blood cell count and the risk of colon cancer. Yonsei Med. J. 47(5), 646\u2013656 (2006).","journal-title":"Yonsei Med. J."},{"key":"28631_CR15","unstructured":"Saif, M. W., Alexander, D., & Wicox, C. M. Serum alkaline phosphatase level as a prognostic tool in colorectal cancer: A study of 105 patients\u2014PMC. J. Appl. Res. [Internet]. 2005; Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2741323\/."},{"issue":"32","key":"28631_CR16","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.3748\/wjg.v16.i32.4084","volume":"16","author":"XZ Wu","year":"2010","unstructured":"Wu, X. Z., Ma, F. & Wang, X. L. Serological diagnostic factors for liver metastasis in patients with colorectal cancer. World J. Gastroenterol. 16(32), 4084\u20134088 (2010).","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"28631_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/gut.2010.225011","volume":"60","author":"FJB van Duijnhoven","year":"2011","unstructured":"van Duijnhoven, F. J. B. et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 60(8), 1094 (2011).","journal-title":"Gut"},{"issue":"721","key":"28631_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3399\/BJGP.2021.0563","volume":"72","author":"M Moullet","year":"2022","unstructured":"Moullet, M. et al. Pre-diagnostic clinical features and blood tests in patients with colorectal cancer: A retrospective linked data study. Br. J. Gen. Pract. 72(721), 563 (2022).","journal-title":"Br. J. Gen. Pract."},{"issue":"3","key":"28631_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow, C. et al. UK Biobank: An open access resource for identifying the causes of a wide range of complex diseases of middle and old age. Plos Med. 12(3), e1001779 (2015).","journal-title":"Plos Med."},{"issue":"40","key":"28631_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.21105\/joss.01317","volume":"4","author":"C Davidson-Pilon","year":"2019","unstructured":"Davidson-Pilon, C. Lifelines: Survival analysis in Python. J. Open Source Softw. 4(40), 1317 (2019).","journal-title":"J. Open Source Softw."},{"key":"28631_CR21","doi-asserted-by":"crossref","unstructured":"Sigrist, F. Latent Gaussian model boosting. IEEE T Pattern Anal. 2, 1894\u20131905 (2022).","DOI":"10.1109\/TPAMI.2022.3168152"},{"key":"28631_CR22","doi-asserted-by":"publisher","unstructured":"Sigrist, F. Gaussian Process Boosting. arXiv [Internet]. 2020; Available from: https:\/\/doi.org\/10.48550\/arXiv.2004.02653.","DOI":"10.48550\/arXiv.2004.02653"},{"key":"28631_CR23","unstructured":"Ke, G., Meng, Q., Finley, T., Wang, T., Chen, W., Ma, W., et al. LightGBM: A Highly Efficient Gradient Boosting Decision Tree. In: NeurIPS Proceedings [Internet]. 2017 [cited 2022 Sep 14]. Available from: https:\/\/papers.nips.cc\/paper\/2017\/hash\/6449f44a102fde848669bdd9eb6b76fa-Abstract.html."},{"issue":"12","key":"28631_CR24","first-page":"2825","volume":"1","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit learn: Machine learning in Python. J. Mach. Learn. Res. 1(12), 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"issue":"10","key":"28631_CR25","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3748\/wjg.v16.i10.1252","volume":"16","author":"S Otake","year":"2010","unstructured":"Otake, S. et al. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J. Gastroenterol. 16(10), 1252\u20131257 (2010).","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"28631_CR26","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/ajg.2013.64","volume":"108","author":"MH Yang","year":"2013","unstructured":"Yang, M. H. et al. The association of serum lipids with colorectal adenomas. Am. J. Gastroenterol. 108(5), 833\u2013841 (2013).","journal-title":"Am. J. Gastroenterol."},{"issue":"21","key":"28631_CR27","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1056\/NEJMoa043792","volume":"352","author":"JN Poynter","year":"2005","unstructured":"Poynter, J. N. et al. Statins and the risk of colorectal cancer. N. Engl. J. Med. 352(21), 2184\u20132192 (2005).","journal-title":"N. Engl. J. Med."},{"issue":"15 suppl","key":"28631_CR28","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1200\/JCO.2016.34.15_suppl.3609","volume":"34","author":"R Mamtani","year":"2016","unstructured":"Mamtani, R. et al. Disentangling the association between statins, cholesterol, and colorectal cancer: A nested case-control study. J. Clin. Oncol. 34(15 suppl), 3609\u20133609 (2016).","journal-title":"J. Clin. Oncol."},{"key":"28631_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.682911","volume":"11","author":"I Giacomini","year":"2021","unstructured":"Giacomini, I. et al. Cholesterol metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy. Front. Oncol. 11, 682911 (2021).","journal-title":"Front. Oncol."},{"issue":"6178","key":"28631_CR30","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1126\/science.1252787","volume":"343","author":"S Silvente-Poirot","year":"2014","unstructured":"Silvente-Poirot, S. & Poirot, M. Cholesterol and cancer, in the balance. Science 343(6178), 1445\u20131446 (2014).","journal-title":"Science"},{"issue":"1","key":"28631_CR31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/hep.30176","volume":"69","author":"DM Green","year":"2019","unstructured":"Green, D. M. et al. Serum alanine aminotransferase elevations in survivors of childhood cancer: A report from the St Jude lifetime cohort study. Hepatology 69(1), 94\u2013106 (2019).","journal-title":"Hepatology"},{"issue":"1","key":"28631_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejca.2012.07.009","volume":"49","author":"RL Mulder","year":"2013","unstructured":"Mulder, R. L. et al. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: Prevalence and risk factors. Eur. J. Cancer. 49(1), 185\u2013193 (2013).","journal-title":"Eur. J. Cancer."},{"issue":"5","key":"28631_CR33","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/ijc.29084","volume":"136","author":"SK Kunutsor","year":"2015","unstructured":"Kunutsor, S. K., Apekey, T. A., Hemelrijck, M. V., Calori, G. & Perseghin, G. Gamma glutamyltransferase, alanine aminotransferase and risk of cancer: Systematic review and meta-analysis. Int. J. Cancer. 136(5), 1162\u20131170 (2015).","journal-title":"Int. J. Cancer."},{"issue":"43","key":"28631_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004821","volume":"95","author":"G Zoppini","year":"2016","unstructured":"Zoppini, G. et al. The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes. Medicine 95(43), e4821 (2016).","journal-title":"Medicine"},{"issue":"1","key":"28631_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1475-2840-11-117","volume":"11","author":"R Kawamoto","year":"2012","unstructured":"Kawamoto, R. et al. Alanine aminotransferase\/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc. Diabetol. 11(1), 117\u2013117 (2012).","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"28631_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11606-015-3480-6","volume":"31","author":"N Peltz-Sinvani","year":"2015","unstructured":"Peltz-Sinvani, N. et al. Low ALT Levels independently associated with 22-year all-cause mortality among coronary heart disease patients. J. Gen. Intern. Med. 31(2), 209\u2013214 (2015).","journal-title":"J. Gen. Intern. Med."},{"issue":"7","key":"28631_CR37","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/cells9071631","volume":"9","author":"HJ Bax","year":"2020","unstructured":"Bax, H. J. et al. Basophils from cancer patients respond to immune stimuli and predict clinical outcome. Cells 9(7), 1631 (2020).","journal-title":"Cells"},{"issue":"23","key":"28631_CR38","first-page":"5386","volume":"21","author":"WW Zhou","year":"2017","unstructured":"Zhou, W. W., Chu, Y. P. & An, G. Y. Significant difference of neutrophil-lymphocyte ratio between colorectal cancer, adenomatous polyp and healthy people. Eur. Rev. Med. Pharm. 21(23), 5386\u20135391 (2017).","journal-title":"Eur. Rev. Med. Pharm."},{"key":"28631_CR39","first-page":"625","volume":"13","author":"B Wondimneh","year":"2021","unstructured":"Wondimneh, B. et al. Comparison of hematological and biochemical profile changes in pre- and post-chemotherapy treatment of cancer patients attended at Ayder comprehensive specialized hospital, Mekelle, Northern Ethiopia 2019: A retrospective cohort study. Cancer Manag. Res. 13, 625\u2013632 (2021).","journal-title":"Cancer Manag. Res."},{"issue":"3","key":"28631_CR40","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/ajcn\/86.3.556","volume":"86","author":"SC Larsson","year":"2007","unstructured":"Larsson, S. C. & Wolk, A. Obesity and colon and rectal cancer risk: A meta-analysis of prospective studies. Am. J. Clin. Nutr. 86(3), 556\u2013565 (2007).","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"28631_CR41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/ije\/dyv177","volume":"45","author":"M Song","year":"2016","unstructured":"Song, M. et al. Long-term status and change of body fat distribution, and risk of colorectal cancer: a prospective cohort study. Int. J. Epidemiol. 45(3), 871\u2013883 (2016).","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"28631_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s13679-014-0129-4","volume":"4","author":"G Traversy","year":"2015","unstructured":"Traversy, G. & Chaput, J. P. Alcohol consumption and obesity: An update. Curr. Obes. Rep. 4(1), 122\u2013130 (2015).","journal-title":"Curr. Obes. Rep."},{"issue":"9","key":"28631_CR43","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1093\/annonc\/mdq653","volume":"22","author":"V Fedirko","year":"2011","unstructured":"Fedirko, V. et al. Alcohol drinking and colorectal cancer risk: An overall and dose\u2013response meta-analysis of published studies. Ann. Oncol. 22(9), 1958\u20131972 (2011).","journal-title":"Ann. Oncol."},{"issue":"2","key":"28631_CR44","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/ijc.31049","volume":"142","author":"H Jayasekara","year":"2018","unstructured":"Jayasekara, H. et al. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype. Int. J. Cancer. 142(2), 238\u2013250 (2018).","journal-title":"Int. J. Cancer."},{"issue":"1","key":"28631_CR45","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1186\/s12885-018-4786-7","volume":"18","author":"A White","year":"2018","unstructured":"White, A. et al. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC Cancer 18(1), 906 (2018).","journal-title":"BMC Cancer"},{"issue":"1","key":"28631_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1108\/NFS-04-2019-0132","volume":"50","author":"M Lombardo","year":"2019","unstructured":"Lombardo, M. et al. Gender differences in taste and foods habits. Nutr. Food Sci. 50(1), 229\u2013239 (2019).","journal-title":"Nutr. Food Sci."},{"key":"28631_CR47","doi-asserted-by":"publisher","first-page":"d1584","DOI":"10.1136\/bmj.d1584","volume":"342","author":"M Schutze","year":"2011","unstructured":"Schutze, M. et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 342, d1584\u2013d1584 (2011).","journal-title":"BMJ"},{"issue":"1","key":"28631_CR48","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof, A. & Despr\u00e9s, J. P. Pathophysiology of human visceral obesity: An update. Physiol. Rev. 93(1), 359\u2013404 (2013).","journal-title":"Physiol. Rev."},{"issue":"5","key":"28631_CR49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10654-016-0116-z","volume":"31","author":"LS M\u00f8rch","year":"2016","unstructured":"M\u00f8rch, L. S., Lidegaard, \u00d8., Keiding, N., L\u00f8kkegaard, E. & Kj\u00e6r, S. K. The influence of hormone therapies on colon and rectal cancer. Eur. J. Epidemiol. 31(5), 481\u2013489 (2016).","journal-title":"Eur. J. Epidemiol."},{"issue":"3","key":"28631_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0010065","volume":"1","author":"LT Amundadottir","year":"2004","unstructured":"Amundadottir, L. T. et al. Cancer as a complex phenotype: Pattern of cancer distribution within and beyond the nuclear family. Plos Med. 1(3), e65 (2004).","journal-title":"Plos Med."},{"issue":"1","key":"28631_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/gim.2011.2","volume":"14","author":"CC Teerlink","year":"2012","unstructured":"Teerlink, C. C., Albright, F. S., Lins, L. & Cannon-Albright, L. A. A comprehensive survey of cancer risks in extended families. Genet Med. 14(1), 107\u2013114 (2012).","journal-title":"Genet Med."},{"issue":"12","key":"28631_CR52","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/ejhf.670","volume":"18","author":"MS Anker","year":"2016","unstructured":"Anker, M. S. et al. Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study. Eur. J. Heart Fail. 18(12), 1524\u20131534 (2016).","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"28631_CR53","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/genes12040498","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Causal associations between serum urea and cancer: A mendelian randomization study. Genes-Basel. 12(4), 498 (2021).","journal-title":"Genes-Basel."},{"key":"28631_CR54","unstructured":"Cancer Research UK. Bowel cancer statistics [Internet]. 2022 [cited 2022 Oct 10]. Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/bowel-cancer#heading-One."},{"issue":"9993","key":"28631_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(15)60175-1","volume":"386","author":"A Ganna","year":"2015","unstructured":"Ganna, A. & Ingelsson, E. 5 year mortality predictors in 498 103 UK Biobank participants: A prospective population-based study. Lancet 386(9993), 533\u2013540 (2015).","journal-title":"Lancet"},{"issue":"5","key":"28631_CR56","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/jamia\/ocv195","volume":"23","author":"Y Kinar","year":"2016","unstructured":"Kinar, Y. et al. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: A binational retrospective study. J. Am. Med. Inform. Assn. 23(5), 879\u2013890 (2016).","journal-title":"J. Am. Med. Inform. Assn."},{"key":"28631_CR57","doi-asserted-by":"crossref","first-page":"153303382110583","DOI":"10.1177\/15330338211058352","volume":"20","author":"H Li","year":"2021","unstructured":"Li, H. et al. Colorectal cancer detected by machine learning models using conventional laboratory test data. Technol. Cancer Res. T. 20, 15330338211058352 (2021).","journal-title":"Technol. Cancer Res. T."},{"issue":"9","key":"28631_CR58","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S2468-1253(21)00147-3","volume":"6","author":"RH Henderson","year":"2021","unstructured":"Henderson, R. H. et al. The economic burden of colorectal cancer across Europe: A population-based cost-of-illness study. Lancet Gastroenterol. Hepatol. 6(9), 709\u2013722 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"28631_CR59","unstructured":"Quantitative faecal immunochemical tests to guide referral for colorectal cancer in primary care [Internet]. National Institute for Health and Care Excellence; 2017 Jul [cited 2022 Oct 20]. Available from: https:\/\/www.nice.org.uk\/guidance\/dg30\/resources\/quantitative-faecal-immunochemical-tests-to-guide-referral-for-colorectal-cancer-in-primary-care-pdf-1053744003781."},{"issue":"1","key":"28631_CR60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12875-021-01435-7","volume":"22","author":"C Kearsey","year":"2021","unstructured":"Kearsey, C. et al. Cost effectiveness of using Faecal Immunochemical Testing (FIT) as an initial diagnostic investigation for patients with lower gastrointestinal symptoms suggestive of malignancy. BMC Fam. Pract. 22(1), 90 (2021).","journal-title":"BMC Fam. Pract."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28631-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T20:03:19Z","timestamp":1674590599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28631-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28631"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28631-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1367"}}